Corporate & Background
 Custom Manufacturing
 Business & Products
 Facilities & Strengths
 Ethics & Values
Corporate Governance
Social Responsibilities
Environment & Safety
IPR Compliance
 Regulatory Submissions
 Investors & Financials
 Sustainability
 Careers
 Locations & Contact
 Media Center
 Enquiry
 Home
     Our Nutraceuticals website
      News & Events

 Divi's Labs earns an Income of Rs.313 crores for Q3 of FY11
 Divi's Labs earns an Income of Rs.265 crores in Q1
 Divi's Labs earns a PAT of Rs.129 crores for Q4
 Divi's Labs earns an Income of Rs.649 crores for 9M of FY10
 Divi's Labs earns an Income of Rs.445 crores in H1 of FY10
 Divi's Labs earns a PAT of Rs.417 for the year 2008-09 And declares 1:1 bonus
 Divi's Labs PAT for 9 months
grows by 21% to Rs.309 crores
 Divi's Labs PAT for Q2 grows by
49% to Rs.135 crores
 Divi's Labs PAT for Q1 grows by
45% to Rs.94 crores
 Divi's Labs PAT for Q4 grows by 87% to Rs.348 crores
 Divi's Labs PAT for Q3 grows by 216% to Rs.99 crores
 Divi's Labs PAT for Q2 grows by 204% to Rs.91 crores
 Divi's Labs PAT for Q1 grows by 153% to Rs.65 crores
 Divi's Labs PAT for FY07
grows by 167% to Rs.186 crores
 Divi's Labs Q3 total income
 grows by 38% to Rs.152 crores
 Divi's successful US-FDA
 inspection for Unit II
 Divi's Labs Q2 total income
 grows by 97% to Rs.165 crores.
 Divi's Labs Q1 total income
 grows by 142% at Rs.165
 crores
 Divi's Laboratories earns
a net of 70 crores on an income
of Rs.392 crores in FY06
 Divi's gets nod for pharma SEZ
 Divi's Laboratories earns a
 PBT of Rs.43 Crores in
 First-Half of FY06
 Divi's Laboratories earns a
 total income of Rs.68
 Crores in Q1 of FY06
 Divi's Laboratories earns a
 total income of Rs.365
 Crores in FY05
 Divi's Laboratories earns a
 Net of Rs.105 Crores in Q3
 Divi's Laboratories earns a
 PBT of Rs.45 Crores in
 First-Half of FY05
 Divi's Laboratories earns a
 Net of Rs.14 Crores in Q1

At Divis we believe results are important but we also believe how we achieve results is equally important. Our commitment to this principle is the key to sustaining our client's trust and confidence in our company.

Our governance structure enables us to manage all the major aspects of the company's business effectively through an integrated process that includes innovation, financial, strategic, risk and process planning. In particular, we made important changes in our processes for managing innovation. As a pharmaceutical company with a broad vision we are in the business of innovating new products and new processes whether we succeed depends largely on how we manage knowledge, creativity and the innovation of our people.

But innovation represents only one side of governance. The other side, corporate culture, is equally important. It is corporate culture championed by leadership and sustained by every employee and stakeholder within and outside the organization that determines good corporate governance.

Good corporate governance is about commitment to values and about ethical business conduct. It is about how an organization is managed. This includes its corporate and other structures, its culture, its policies and the manner in which it deals with various stakeholders. Accordingly, timely and accurate disclosure of information regarding the financial situation, performance, ownership and governance of the company, is an important part of corporate governance. Divis believes that this improves public understanding of the structure, activities and policies of the organization. Consequently, the organization is able to attract investors and to enhance the trust and confidence of the stakeholders.

Corporate Governance 2013-14 Corporate_Governance_Report_2014
Corporate Governance 2012-13 Corporate_Governance_Report_2013
Corporate Governance 2011-12 Corporate_Governance_Report_2012
Corporate Governance 2010-11 Corporate_Governance_Report_2011
Corporate Governance 2009-10 Corporate Governance 2009-10
Corporate Governance 2008-09 Corporate Governance 2008-09
Corporate Governance 2007-08 Corporate Governance 2007-08
Chairman speech 2012-13 Chairman speech 2012-13
Chairman speech 2011-12 Chairman speech 2011-12
Chairman speech 2010-11 Chairman speech 2010-11
Chairman speech 2009-10 Chairman speech 2009-10
Chairman speech 2008-09 Chairman Speech 2007-08
Chairman speech 2007-08 Chairman Speech 2007-08
Chairman speech 2006-07 Chairman Speech 2006-07
top
Copyright © 2006, Divis Laboratories Ltd. All Rights Reserved      Website Designed by Sumudra